European Journal of Radiology, ISSN 0720-048X, 11/2019, Volume 120, p. 108699
The most commonly used technique for guiding the surgical removal of impalpable breast lesions is wire-guided localization (WGL). Potential complications of...
Magnetic probe | Breast tumors | Sentinel lymph nodes | Iron oxide nanoparticles | Breast surgery | Magnetic seed | Impalpable breast lesions | METAANALYSIS | BIOPSY | CANCER | SPECIMEN RADIOGRAPHY | NANOPARTICLES | CONSERVING SURGERY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Magnetic probe | Breast tumors | Sentinel lymph nodes | Iron oxide nanoparticles | Breast surgery | Magnetic seed | Impalpable breast lesions | METAANALYSIS | BIOPSY | CANCER | SPECIMEN RADIOGRAPHY | NANOPARTICLES | CONSERVING SURGERY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
European Journal of Cancer, ISSN 0959-8049, 01/2019, Volume 106, pp. 54 - 60
An international panel of experts representing 17 European countries and Israel convened to discuss current needs and future developments in testing and...
BRCA | Metastatic breast cancer | Hereditary breast cancer | BRCA1 | Genetic testing | BRCA2 | Genetic counselling | MASTECTOMY | GUIDELINES | RISK | CARRIERS | ONCOLOGY | MUTATIONS | Decision-making | Genetic counseling | Genes | Breast cancer | Disease susceptibility | Genetic aspects | Health aspects | Cancer | Ovarian carcinoma | Risk groups | BRCA1 protein | Decision making | ADP | ErbB-2 protein | Genetic screening | Ovarian cancer | Polymerase | Epidermal growth factor | Ribose | Breast | Genetics | Growth factors | Quality of care | Genetic disorders | Metastasis | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Cancer and Oncology | Cancer och onkologi
BRCA | Metastatic breast cancer | Hereditary breast cancer | BRCA1 | Genetic testing | BRCA2 | Genetic counselling | MASTECTOMY | GUIDELINES | RISK | CARRIERS | ONCOLOGY | MUTATIONS | Decision-making | Genetic counseling | Genes | Breast cancer | Disease susceptibility | Genetic aspects | Health aspects | Cancer | Ovarian carcinoma | Risk groups | BRCA1 protein | Decision making | ADP | ErbB-2 protein | Genetic screening | Ovarian cancer | Polymerase | Epidermal growth factor | Ribose | Breast | Genetics | Growth factors | Quality of care | Genetic disorders | Metastasis | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Clinical Medicine | Cancer and Oncology | Cancer och onkologi
Journal Article
Nanomedicine, ISSN 1743-5889, 12/2018, Volume 13, Issue 24, pp. 3075 - 3081
Aim: In this study we used a new technology for localization of non-palpable breast tumors using a small steel marker in conjunction of sentinel nodes (SLNs)...
breast cancer | impalpable breast lesions | sentinel lymph nodes | breast surgery | iron oxide nanoparticles | TC-99 | BIOPSY | SENTIMAG | NANOSCIENCE & NANOTECHNOLOGY | NANOPARTICLES | TRACER | SUPERPARAMAGNETIC IRON-OXIDE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | UPDATE
breast cancer | impalpable breast lesions | sentinel lymph nodes | breast surgery | iron oxide nanoparticles | TC-99 | BIOPSY | SENTIMAG | NANOSCIENCE & NANOTECHNOLOGY | NANOPARTICLES | TRACER | SUPERPARAMAGNETIC IRON-OXIDE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | UPDATE
Journal Article
The American Journal of Cosmetic Surgery, ISSN 0748-8068, 9/2018, Volume 35, Issue 3, pp. 105 - 109
Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal proliferative breast condition. Although its prevalence is difficult to accurately...
Journal Article
Oncology Letters, ISSN 1792-1074, 2017, Volume 14, Issue 2, pp. 1433 - 1438
Mammary fibromatosis is a rare and locally aggressive benign tumor of the breast; it originates from fibroblasts and myofibroblasts within the breast...
Breast tumors | Desmoid-type fibromatosis | breast tumors | MANAGEMENT | ONCOLOGY | desmoid-type fibromatosis | TUMORS
Breast tumors | Desmoid-type fibromatosis | breast tumors | MANAGEMENT | ONCOLOGY | desmoid-type fibromatosis | TUMORS
Journal Article
International Journal of Surgery Case Reports, ISSN 2210-2612, 2019, Volume 56, pp. 74 - 77
Secretory breast carcinoma (SBC) is a rare breast tumor which accounts for < 0.15% of all breast cancers. It was originally described as a juvenile breast...
Immunohistochemistry | Sectretory carcinoma | Case report | Breast imaging | Breast surgery | Fluorescence in situ hybridization | Breast cancer
Immunohistochemistry | Sectretory carcinoma | Case report | Breast imaging | Breast surgery | Fluorescence in situ hybridization | Breast cancer
Journal Article
Tumor Biology, ISSN 1010-4283, 5/2015, Volume 36, Issue 5, pp. 3423 - 3428
Approximately 6–15 % of breast cancer patients are diagnosed with primary ulcerated breast cancer (ULBC). ULBC is known to be associated with short recurrence...
Locally advanced breast cancer | Cancer Research | Ulcerated breast cancer | Breast cancer | Biomedicine | Prognostic factors | SURVIVAL | NONINFLAMMATORY SKIN INVOLVEMENT | PROGNOSTIC-FACTORS | SOCIETY | FEATURES | WOMEN | INVASION | THERAPY | ONCOLOGY | RECOMMENDATIONS | CARCINOMA | Neoplasm Metastasis | Ki-67 Antigen - analysis | Ulcer - pathology | Breast Neoplasms - pathology | Humans | Middle Aged | Female | Aged | Medical colleges | Health aspects | Analysis | Singers | Comparative studies | Histology | Medical prognosis
Locally advanced breast cancer | Cancer Research | Ulcerated breast cancer | Breast cancer | Biomedicine | Prognostic factors | SURVIVAL | NONINFLAMMATORY SKIN INVOLVEMENT | PROGNOSTIC-FACTORS | SOCIETY | FEATURES | WOMEN | INVASION | THERAPY | ONCOLOGY | RECOMMENDATIONS | CARCINOMA | Neoplasm Metastasis | Ki-67 Antigen - analysis | Ulcer - pathology | Breast Neoplasms - pathology | Humans | Middle Aged | Female | Aged | Medical colleges | Health aspects | Analysis | Singers | Comparative studies | Histology | Medical prognosis
Journal Article
Oncology Letters, ISSN 1792-1074, 2017, Volume 14, Issue 1, pp. 993 - 998
Dermatofibrosarcoma protuberans (DFSP) is a rare malignant tumor of subcutaneous tissue characterized by slow infiltrative growth. The tumor occurs in patients...
Breast tumor | Dermatofibrosarcoma protuberans | TARGET | dermatofibrosarcoma protuberans | breast tumor | COL1A1-PDGFB | ONCOLOGY | IMAGING FINDINGS | IMATINIB | TUMOR | MOHS | UPDATE | FEATURES
Breast tumor | Dermatofibrosarcoma protuberans | TARGET | dermatofibrosarcoma protuberans | breast tumor | COL1A1-PDGFB | ONCOLOGY | IMAGING FINDINGS | IMATINIB | TUMOR | MOHS | UPDATE | FEATURES
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2014, Volume 32, Issue 15_suppl, pp. e11519 - e11519
Journal Article
International journal of surgical pathology, 12/2016, Volume 24, Issue 8, p. 738
Primary neuroendocrine carcinoma of the breast is a rare tumor that comprises less than 1% of breast carcinomas, with most patients being in the sixth or...
Immunohistochemistry | Carcinoma, Neuroendocrine - diagnosis | Neoplasm Grading | Biomarkers, Tumor - analysis | Breast Neoplasms - pathology | Carcinoma, Neuroendocrine - pathology | Humans | Adult | Female | Breast Neoplasms - diagnosis | Cell Differentiation | Disease Progression
Immunohistochemistry | Carcinoma, Neuroendocrine - diagnosis | Neoplasm Grading | Biomarkers, Tumor - analysis | Breast Neoplasms - pathology | Carcinoma, Neuroendocrine - pathology | Humans | Adult | Female | Breast Neoplasms - diagnosis | Cell Differentiation | Disease Progression
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2012, Volume 30, Issue 27_suppl, pp. 21 - 21
21 Background: Ulcerated breast carcinomas belong to the group of locally advanced breast cancers. In this study, the authors analyzed the biological...
Journal Article
International Journal of Surgical Pathology, ISSN 1066-8969, 12/2016, Volume 24, Issue 8, pp. 738 - 742
Primary neuroendocrine carcinoma of the breast is a rare tumor that comprises less than 1% of breast carcinomas, with most patients being in the sixth or...
histopathology | breast cancer | diagnosis | neuroendocrine tumors | SURGERY | PATHOLOGY | TUMORS | Women | Squamous cell carcinoma | Usage | Breast cancer | Diagnosis | Research | Histology, Pathological | Health aspects
histopathology | breast cancer | diagnosis | neuroendocrine tumors | SURGERY | PATHOLOGY | TUMORS | Women | Squamous cell carcinoma | Usage | Breast cancer | Diagnosis | Research | Histology, Pathological | Health aspects
Journal Article
Oncology Letters, ISSN 1792-1074, 12/2016, Volume 12, Issue 6, pp. 4393 - 4398
Loss of expression of cadherin-11 protein is correlated with a loss of epithelial phenotype and a gain in tumor cell proliferation and invasion. It has been...
Normal breasttissue | Cadherin-11 | Breastcancer | EPITHELIAL-MESENCHYMAL TRANSITION | CELLS | ONCOLOGY | CATENIN | breast cancer | COHORT | cadherin-11 | normal breast tissue
Normal breasttissue | Cadherin-11 | Breastcancer | EPITHELIAL-MESENCHYMAL TRANSITION | CELLS | ONCOLOGY | CATENIN | breast cancer | COHORT | cadherin-11 | normal breast tissue
Journal Article
Molecular and clinical oncology, ISSN 2049-9450, 04/2018, Volume 8, Issue 4, p. 582
A granular cell tumor (GCT), is a rare soft tissue tumor which may occur throughout the body, usually in the head and neck, skin or subcutaneous tissues of the...
Journal Article
Molecular and clinical oncology, ISSN 2049-9450, 06/2018, Volume 8, Issue 6, p. 749
Myositis ossificans (MO) is characterized by abnormal heterotopic ossification formation, typically involving muscles, tendons, ligaments, fascia, and...
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2007, Volume 13, Issue 14, pp. 4185 - 4190
Purpose: Tibolone is a selective tissue estrogenic activity regulator, approved for the treatment of vasomotor symptoms in postmenopausal women. We have done...
apoptosis | breast cancer | proliferation | tibolone | IN-VITRO | METABOLITES | ONCOLOGY | DOUBLE-BLIND | HORMONE-REPLACEMENT THERAPY | MENOPAUSAL SYMPTOMS | PLACEBO-CONTROLLED TRIAL | PREVALENCE | WOMENS HEALTH | HOT FLASHES | ORG OD14 | Breast Neoplasms - surgery | Norpregnenes - adverse effects | Humans | Middle Aged | Combined Modality Therapy | Breast Neoplasms - drug therapy | Cell Division - drug effects | Antineoplastic Agents, Hormonal - adverse effects | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Placebos | Postmenopause | Female | Aged | Safety | Norpregnenes - therapeutic use
apoptosis | breast cancer | proliferation | tibolone | IN-VITRO | METABOLITES | ONCOLOGY | DOUBLE-BLIND | HORMONE-REPLACEMENT THERAPY | MENOPAUSAL SYMPTOMS | PLACEBO-CONTROLLED TRIAL | PREVALENCE | WOMENS HEALTH | HOT FLASHES | ORG OD14 | Breast Neoplasms - surgery | Norpregnenes - adverse effects | Humans | Middle Aged | Combined Modality Therapy | Breast Neoplasms - drug therapy | Cell Division - drug effects | Antineoplastic Agents, Hormonal - adverse effects | Breast Neoplasms - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Placebos | Postmenopause | Female | Aged | Safety | Norpregnenes - therapeutic use
Journal Article
The Journal of Pathology, ISSN 0022-3417, 07/2002, Volume 197, Issue 3, pp. 314 - 321
CA IX is a tumour‐associated carbonic anhydrase with proposed roles in pH modulation and intercellular communication. Its distribution was examined in normal,...
carbonic anhydrase IX | immunohistochemistry | semi‐quantitative RT‐PCR | breast carcinogenesis | c‐erbB2 | Immunohistochemistry | Carbonic anhydrase IX | c-erbB2 | Semiquantitative RT-PCR | Breast carcinogenesis | PAPANICOLAOU SMEARS | POTENTIAL BIOMARKER | CERVICAL DYSPLASIA | MN ANTIGEN | PATHOLOGY | CANCER | RENAL-CELL CARCINOMA | MN/CA-IX | IN-VITRO | EPITHELIAL-CELLS | ONCOLOGY | DIAGNOSTIC BIOMARKER | semiquantitative RT-PCR | Antigens, Neoplasm | Biomarkers, Tumor - analysis | Humans | Middle Aged | Receptors, Estrogen - analysis | Chi-Square Distribution | Reverse Transcriptase Polymerase Chain Reaction | Hyaluronan Receptors - analysis | Breast - chemistry | Breast Neoplasms - chemistry | Breast Neoplasms - genetics | Genes, erbB-2 | Aged, 80 and over | Adult | Female | Neoplasm Proteins - analysis | Aged | Carbonic Anhydrases - analysis | Carbonic Anhydrase IX
carbonic anhydrase IX | immunohistochemistry | semi‐quantitative RT‐PCR | breast carcinogenesis | c‐erbB2 | Immunohistochemistry | Carbonic anhydrase IX | c-erbB2 | Semiquantitative RT-PCR | Breast carcinogenesis | PAPANICOLAOU SMEARS | POTENTIAL BIOMARKER | CERVICAL DYSPLASIA | MN ANTIGEN | PATHOLOGY | CANCER | RENAL-CELL CARCINOMA | MN/CA-IX | IN-VITRO | EPITHELIAL-CELLS | ONCOLOGY | DIAGNOSTIC BIOMARKER | semiquantitative RT-PCR | Antigens, Neoplasm | Biomarkers, Tumor - analysis | Humans | Middle Aged | Receptors, Estrogen - analysis | Chi-Square Distribution | Reverse Transcriptase Polymerase Chain Reaction | Hyaluronan Receptors - analysis | Breast - chemistry | Breast Neoplasms - chemistry | Breast Neoplasms - genetics | Genes, erbB-2 | Aged, 80 and over | Adult | Female | Neoplasm Proteins - analysis | Aged | Carbonic Anhydrases - analysis | Carbonic Anhydrase IX
Journal Article
The Journal of Pathology, ISSN 0022-3417, 07/2002, Volume 197, Issue 3, pp. 314 - 321
Journal Article
Oncology Research and Treatment, ISSN 2296-5270, 1994, Volume 17, Issue 3, pp. 242 - 247
Angiosarcoma of the breast represents a rare breast neoplasm, which generally has a rapid fatal outcome due to its advanced stage at the clinical presentation,...
Kurze Übersicht – Short Review | adjuvant chemotherapy | angiosarcomas | sarcomas | breast neoplasms | BREAST NEOPLASMS | ADJUVANT CHEMOTHERAPY | ANGIOSARCOMAS | ONCOLOGY | VASCULAR TUMORS | SARCOMAS
Kurze Übersicht – Short Review | adjuvant chemotherapy | angiosarcomas | sarcomas | breast neoplasms | BREAST NEOPLASMS | ADJUVANT CHEMOTHERAPY | ANGIOSARCOMAS | ONCOLOGY | VASCULAR TUMORS | SARCOMAS
Journal Article
Journal of Histotechnology, ISSN 0147-8885, 06/2000, Volume 23, Issue 2, pp. 105 - 111
Immunohistochemical methods were used to study the expression of prostate-specific antigen (PSA) in more than 400 samples of normal and pathological human...
small vessel endothelium | apocrinc metaplasia | gastric parietal cells | Skene's gland | adipocytes | female breast | Female breast | Adipocytes | Gastric parietal cells | Apocrine metaplasia | Small vessel endothelium | SKENES PARAURETHRAL GLANDS | IMMUNOREACTIVITY | CANCER | TUMORS | CELL BIOLOGY | CLEAR-CELL ADENOCARCINOMA | PERIURETHRAL GLANDS | IMMUNOCYTOCHEMICAL DETECTION | URETHRA | apocrine metaplasia | ACID-PHOSPHATASE | CLINICOPATHOLOGICAL ANALYSIS
small vessel endothelium | apocrinc metaplasia | gastric parietal cells | Skene's gland | adipocytes | female breast | Female breast | Adipocytes | Gastric parietal cells | Apocrine metaplasia | Small vessel endothelium | SKENES PARAURETHRAL GLANDS | IMMUNOREACTIVITY | CANCER | TUMORS | CELL BIOLOGY | CLEAR-CELL ADENOCARCINOMA | PERIURETHRAL GLANDS | IMMUNOCYTOCHEMICAL DETECTION | URETHRA | apocrine metaplasia | ACID-PHOSPHATASE | CLINICOPATHOLOGICAL ANALYSIS
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.